Cellect Biotechnology Ltd. ADR | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.86 |
Market Cap |
$3.03 M |
Shares Outstanding |
5.6 M |
Public Float |
- |
Address |
23 Hata'as Street Kfar Saba JM 44425 Israel |
Employees | - |
Website | http://cellect.co |
Updated | 07/08/2019 |
Cellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods. |